Crinetics Pharmaceuticals CRNX
NASDAQ CRNX
$84.95 +0.00 (+0.00%)
At close: Sep 2, 2026 · 4:00 PM EDT

Crinetics Pharmaceuticals (CRNX) Treasury Shares (2017 - 2025)

Crinetics Pharmaceuticals (CRNX) posted quarterly Treasury Shares of $112000.0 for Q2 2025.

Analysis

Crinetics Pharmaceuticals (CRNX) Treasury Shares (2017 - 2025) Analysis & Trends

Crinetics Pharmaceuticals' Treasury Shares history runs 1 years deep, the most recent figure standing at $112000.0 for Q2 2025.

  • In Q2 2018, Treasury Shares changed N/A year-over-year to $48.4 million; the TTM figure through Jun 2018 stood at $48.4 million (changed N/A YoY), while the FY2017 annual figure was $28.8 million, up 66.67% from the prior year.
  • Treasury Shares for Q2 2018 stood at $48.4 million, roughly flat from $48.4 million in the prior quarter.
  • The five-year high for Treasury Shares was $48.4 million in Q2 2018, with the low at $28.8 million in Q4 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 36.40 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - 2.72 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Crinetics Pharmaceuticals 8.99 Bn 8.99 Bn 24.96 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 112,000.00
Jun 30, 2025 112,000.00
Jun 30, 2018 48.40 Mn
Jun 30, 2018 48.40 Mn
Mar 31, 2018 48.40 Mn
Mar 31, 2018 48.40 Mn
Dec 31, 2017 28.76 Mn
Dec 31, 2017 28.76 Mn